SIGA TECHNOLOGIES INC (SIGA)
US8269171067 - Common Stock
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno...
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy...
Notable Monday Option Activity: CAL, UPST, SIGA
YieldBoost SIGA From 9.6% To 17.2% Using Options
SIGA Crosses Above Key Moving Average Level
SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced...
Bragar Eagel & Squire, P.C. Is Investigating CSX, Stride, and SIGA and Encourages Investors to Contact the Firm
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws
/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...
SIGA Announces Agreement to Supply TPOXX® in Morocco
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
Oversold Conditions For SIGA Technologies
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws
/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws
/PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
SIGA Crosses Below Key Moving Average Level
SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in...
Immunome Stock Sees RS Rating Jump To 91
Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
The Relative Strength (RS) Rating for PTC Therapeutics stock climbed into a new percentile Monday, with a rise from 80 to 83.
Noteworthy Thursday Option Activity: SIGA, DUK, CIEN
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released
Preliminary analysis shows the study did not reach statistical significance on its primary endpoint of tecovirimat being superior to placebo in lesion...